Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome
Rett syndrome (RTT), a severe X-linked neurodevelopmental disorder, is primarily caused by mutations in the methyl CpG binding protein 2 gene (<i>MECP2</i>). Over 35% RTT patients carry nonsense mutation in <i>MECP2</i>, making it a suitable candidate disease for nonsense sup...
Main Authors: | Keit Men Wong, Eike Wegener, Alireza Baradaran-Heravi, Brenda Huppke, Jutta Gärtner, Peter Huppke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/14/11665 |
Similar Items
-
Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
by: Renata B. V. Abreu, et al.
Published: (2022-06-01) -
Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations
by: Daniel R. McHugh, et al.
Published: (2020-12-01) -
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
by: Shan Li, et al.
Published: (2023-06-01) -
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
by: Silvia Lombardi, et al.
Published: (2020-12-01) -
Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
by: Sylwia Michorowska
Published: (2021-08-01)